Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Free Cash Flow (2016 - 2026)

Biomerica's Free Cash Flow history spans 17 years, with the latest figure at -$1.2 million for Q1 2026.

  • Quarterly results put Free Cash Flow at -$1.2 million for Q1 2026, down 19.62% from a year ago — trailing twelve months through Feb 2026 was -$3.2 million (up 25.38% YoY), and the annual figure for FY2025 was -$3.8 million, up 29.03%.
  • Free Cash Flow for Q1 2026 was -$1.2 million at Biomerica, down from -$991000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $2.3 million in Q1 2022 to a low of -$4.3 million in Q2 2022.
  • The 5-year median for Free Cash Flow is -$1.1 million (2024), against an average of -$1.1 million.
  • Peak annual rise in Free Cash Flow hit 266.35% in 2022, while the deepest fall reached 2373.15% in 2022.
  • Year by year, Free Cash Flow stood at -$1.2 million in 2022, then soared by 31.45% to -$848000.0 in 2023, then increased by 6.72% to -$791000.0 in 2024, then fell by 25.28% to -$991000.0 in 2025, then dropped by 26.14% to -$1.2 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$1.2 million, -$991000.0, and -$268000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.